Search

The market is at all-time highs, and some think a correction is imminent. Should you still be buying stocks? Our investing experts weigh in.

My career at Cabot began back in June 1999, just before the internet bubble really revved up in October. That was a time of great divergences—the broad market struggled all the way from the mini-bear market bottom of October 1998 right through the top in March 2000. Today I see a similar dichotomy in the market—many “old” leaders are struggling while “new” growth concepts are finding support.

There are five growth stocks in our Cabot Undervalued Stocks Advisor portfolios that offer dividend yields in excess of 5%. That’s crazy! Stocks with rising profits in combination with very large dividend yields are generally uncommon, and can indicate an extreme undervaluation of those companies’ share prices. Dividends can tell you a lot about a company, or about the broader stock market. I cover the dividend topic in more detail in today’s issue.

Explorer stocks had a mixed week due to weaker market and some profit taking as SQM reported another strong quarter with earnings up 857% year-over-year. Positive second-quarter corporate earnings reports and the flattening of still-high inflation seemed to settle investor nerves and despite this week’s pullback, the S&P is up 17% from its June lows. This week we go to a big resource play on a strategic growth trend that is powered by Dr. Copper.

In today’s note, we discuss pertinent developments and institutional ratings changes for some of the stocks in the portfolio, including Agnico Eagle Mines (AEM), Alcoa (AA), American Airlines (AAL), Atlassian (TEAM) and Toast Inc. (TOST).

I’d like to start off today with two true stories. The first is about my great-grandfather, Carlton Gardner Lutts, an inventor, entrepreneur and metallurgist. Between 1929 and 1954 while working at the Boston Navy Yard, he developed and patented several improved methods of manufacturing anchor chains. That’s a diagram from one...

The action of the last couple of days has been a smack in the face for all investors, U.S. and emerging markets alike. As always, the Cabot growth disciplines tell us not to panic, but also not just to sit there and let the market take away your money. While we don’t have any changes to the portfolio tonight, this issue of Cabot Emerging Markets Investor shows a distinctly defensive tone, with a very heavy cash position and just two stocks rated Buy. We also have a new stock this week that’s perfectly suited to conditions. It’s a commodity play with a generous dividend, attractive valuation and a simple story. Read on for all the details.

This week’s note includes our comments on earnings from Adient (ADNT), Ammo, Inc (POWW), Bayer AG (BAYRY), Berkshire Hathaway (BRK/B), Brookfield Re (BNRE), Elanco Animal Health (ELAN), Goodyear Tire & Rubber (GT), L.B. Foster (FSTR), TreeHouse Foods (THS) and Warner Bros Discovery (WBD). The earnings deluge continues next week.

Stocks continue to chug along in the same range they’ve largely been in since the end of March. We’ll see if this week’s inflation reports (CPI on Wednesday, PPI on Thursday) move the needle in either direction. In the meantime, one sector that is finally showing signs of life after two years of being beaten to a pulp is cannabis. And so today, we add one of the top cannabis stocks recommended by Cabot Cannabis Investor Chief Analyst Michael Brush. It’s a familiar name to even intermediate-term Stock of the Week readers – and it was up 25% last week!

Details inside.

2024 was a rough year for cannabis investors, but 2025 could be much better. Here are my top eight predictions for the cannabis sector for the year ahead.

Cabot Top Ten Trader, our weekly advisory, details the strongest stocks of the previous week.

Tesla (TSLA) is on the way to becoming one of those stocks that turn $1 into $100, and what I particularly like about the company is its CEO Elon Musk.

The pros and cons of the rise of the Internet and similar technology.

These investing tips can help you become a more successful investor.

While long-term prospects for the cannabis industry remain excellent, the sector as a whole remains in correction mode today, with the big Canadian stocks under the greatest pressure—and no one knows where the bottom is, though history tells us it will come when the last holdout capitulates.

A few incidents that have received national attention in recent weeks have got me thinking.

Last year, I started writing a series explaining our investment advisories in an effort to help answer one of the most common questions we get from investors, “Which Cabot publication is right for me?” Also last year, we expanded the Cabot family by purchasing Dick Davis Digest and Income Digest. This is what Timothy Lutts wrote at the time: “Now, it’s our honor to be the steward of these well-respected publications. Our goal is to honor the past reputation of these Digests, while improving the newsletters so they serve subscribers better in this Internet age. I’ll be telling you much more about these Digests in the future.”